CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

BACKGROUND: Various biomarkers for prediction of distant metastasis in lymph-node negative breast cancer have been described; however, predictive biomarkers for patients with lymph-node positive (LNP) disease in the context of distinct systemic therapies are still very much needed. DNA methylation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietrich, Dimo, Krispin, Manuel, Dietrich, Jörn, Fassbender, Anne, Lewin, Jörn, Harbeck, Nadia, Schmitt, Manfred, Eppenberger-Castori, Serenella, Vuaroqueaux, Vincent, Spyratos, Frédérique, Foekens, John A, Lesche, Ralf, Martens, John WM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893112/
https://www.ncbi.nlm.nih.gov/pubmed/20515469
http://dx.doi.org/10.1186/1471-2407-10-247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893112/
https://www.ncbi.nlm.nih.gov/pubmed/20515469
http://dx.doi.org/10.1186/1471-2407-10-247

Ejemplares similares